J. Peter Cegielski

Centers for Disease Control and Prevention

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: “Population Pharmacokinetics of Linezolid in Tuberculosis Patients: Dosing Regimen Simulation and Target Attainment Analysis”.

Population Pharmacokinetics of Linezolid in Tuberculosis Patients: Dosing Regimen Simulation and Target Attainment Analysis

Antimicrobial Agents and Chemotherapy(2020)10.1128/aac.01174-20

N/A

0DataRank · unranked

44 citations

Mohammad H. Al‐Shaer, Guohua An, Abdullah Alsultan, Maia Kipiani, Ketevan Barbakadze +7 more

Isoniazid and Rifampin-Resistance Mutations Associated With Resistance to Second-Line Drugs and With Sputum Culture Conversion

The Journal of Infectious Diseases(2020)10.1093/infdis/jiaa042

N/A

0DataRank · unranked

20 citations

Ekaterina V. Kurbatova, Heather Alexander, Tracy Dalton, Michael P. Chen, James E. Posey +3 more

Ethionamide Population Pharmacokinetic Model and Target Attainment in Multidrug-Resistant Tuberculosis

Antimicrobial Agents and Chemotherapy(2020)10.1128/aac.00713-20

N/A

0DataRank · unranked

6 citations

Anne‐Grete Märtson, Wael A. Alghamdi, Abdullah Alsultan, Guohua An, Shahriar Ahmed +9 more

Quantification of multidrug-resistant M. tuberculosis bacilli in sputum during the first 8 weeks of treatment

The International Journal of Tuberculosis and Lung Disease(2022)10.5588/ijtld.21.0741

N/A

0DataRank · unranked

2 citations

Kathleen D. Eisenach, Moses Joloba, Willy Ssengooba, Carolyn Namaganda, Mary Nsereko +4 more

Implementation of Bedaquiline, Pretomanid, and Linezolid in the United States: Experience Using a Novel All-Oral Treatment Regimen for Treatment of Rifampin-Resistant or Rifampin-Intolerant Tuberculosis Disease

Clinical Infectious Diseases(2023)10.1093/cid/ciad312

N/A

0DataRank · unranked

46 citations

Marcos C. Schechter, David Ashkin, Charles A. Peloquin, J. Peter Cegielski, Barbara B Andrino +95 more

A roadmap for integrating nutritional assessment, counselling, and support into the care of people with tuberculosis

The Lancet Global Health(2025)10.1016/s2214-109x(25)00021-x

N/A

0DataRank · unranked

19 citations

Madhavi Bhargava, Madeline Carwile, Madolyn Dauphinais, Phumeza Tisile, Chelsie Cintron +12 more

Body mass index and tuberculosis risk: an updated systematic literature review and dose–response meta-analysis

International Journal of Epidemiology(2025)10.1093/ije/dyaf154

N/A

0DataRank · unranked

9 citations

J. Peter Cegielski, Rebecca A. Clark, Rein M G J Houben, Christopher Finn McQuaid, Matthew J Saunders

Tuberculosis and undernutrition: improving estimates to reinforce the policy imperative

The Lancet Infectious Diseases(2025)10.1016/s1473-3099(25)00626-7

N/A

0DataRank · unranked

2 citations

Pranay Sinha, J. Peter Cegielski, Rebecca A. Clark, James A. Seddon, Leonardo Martínez +6 more